Business
Press Release Feb 07 2023
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated February 07, 2023, titled "Aurobindo Pharma receives USFDA Approval for Diclofenac Sodium Topical Solution.".
About this update from Aurobindo Pharma Ltd
[{"type":"text","content":" Aurobindo Pharma Limited has informed the Exchange regarding a press release dated February 07, 2023, titled \"Aurobindo Pharma receives USFDA Approval for Diclofenac Sodium Topical Solution.\". View Attachment","length":355,"tagName":"div"}]